Functional bowel symptoms in the general population (Review)

Ohlsson,Bodil

doi:10.3892/mmr.2022.12742

Functional bowel symptoms in the general population (Review)

Authors:
- Bodil Ohlsson
View Affiliations

Affiliations: Department of Internal Medicine, Lund University, Skåne University Hospital, SE-20502 Malmö, Sweden
Published online on: May 20, 2022 https://doi.org/10.3892/mmr.2022.12742
Article Number: 226
Copyright: © Ohlsson . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several patients with irritable bowel syndrome (IBS) do not seek medical attention for their symptoms. When patients with IBS seek help, the majority of them are handled at primary healthcare centers, whereas research studies are performed at tertiary healthcare centers. The present study aimed to summarize findings from >4,000 participants of the general population included in the Malmö Offspring Study (inclusion rate 46.7%). The participants were clinically examined, their blood and fecal samples collected, and their questionnaires completed. The participants were divided into subjects with or without self‑reported IBS and those having functional gastrointestinal (GI) symptoms in the past 2 weeks. The presence of IBS and GI symptoms in the participants were associated with each other. Zonulin levels did not differ between participants with or without GI diseases and were not associated with the degree of GI symptoms. The parameters low body weight at birth and small for gestational age were associated with the degree of the symptoms' influence on daily life. IBS and GI symptoms were positively associated with Blautia abundance. Beta‑diversity differed between participants with or without these two conditions. Positive correlations were noted between the degree of diarrhea and the mean 24‑h measurements of systolic blood pressure, diastolic blood pressure, and heart rate. Both IBS and GI symptoms were associated with female sex, smoking, stress, poor sleeping habits, unemployment, drug use, and a family history of GI diseases, whereas younger age was inversely associated with IBS and its associated symptoms. In conclusion, only a limited number of medical findings could be identified in participants with IBS and GI symptoms, whereas sociodemographic and environmental conditions were associated with these entities.

View Figures

View References

1	Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M and Spiller R: Bowel disorders. Gastroenterology. 150:1393–1407.e5. 2016. View Article : Google Scholar
2	Lovell RM and Ford AC: Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol. 10:712–721.e4. 2012. View Article : Google Scholar
3	Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, et al: Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 160:99–114.e3. 2021. View Article : Google Scholar : PubMed/NCBI
4	Canavan C, West J and Card T: The epidemiology of irritable bowel syndrome. Clin Epidemiol. 6:71–80. 2014.
5	Van den Houte K, Carbone F, Pannemans J, Corsetti M, Fischler B, Piessevaux H and Tack J: Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J. 7:307–315. 2019. View Article : Google Scholar : PubMed/NCBI
6	Nam SY, Kim BC, Ryu KH and Park BJ: Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests. J Neurogastroenterol Motil. 16:47–51. 2010. View Article : Google Scholar
7	Nilholm C, Larsson E, Sonestedt E, Roth B and Ohlsson B: Assessment of a 4-week starch- and sucrose-reduced diet and its effects on gastrointestinal symptoms and inflammatory parameters among patients with irritable bowel syndrome. Nutrients. 13:4162021. View Article : Google Scholar : PubMed/NCBI
8	Singh P and Lembo A: Emerging role of the gut microbiome in irritable bowel syndrome. Gastroenterol Clin North Am. 50:523–545. 2021. View Article : Google Scholar : PubMed/NCBI
9	Fasano A: Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 1258:25–33. 2012. View Article : Google Scholar
10	Bonfiglio F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, Bujanda L, Bresso F, Agreus L, Andreasson A, Dlugosz A, Lindberg G, et al: Female-specific association between variants on chromosome 9 and self-reported diagnosis of irritable bowel syndrome. Gastroenterology. 155:168–179. 2018. View Article : Google Scholar : PubMed/NCBI
11	Axelrod FB: Familial dysautonomia. Muscle Nerve. 29:352–363. 2004. View Article : Google Scholar : PubMed/NCBI
12	Hamrefors V, Fedorowski A and Ohlsson B: Susceptibility to diarrhea is related to hemodynamic markers of sympathetic activation in the general population. Scand J Gastroenterol. 54:1426–1432. 2019. View Article : Google Scholar
13	Raju TNK, Buist AS, Blaisdell CJ, Moxey-Mims M and Saigal S: Adults born preterm: A review of general health and system-specific outcomes. Acta Paediatr. 106:1409–1437. 2017. View Article : Google Scholar : PubMed/NCBI
14	Raslau D, Herrick LM, Locke GR, Schleck CD, Zinsmeister AR, Almazar A, Talley NJ and Saito YA: Irritable bowel syndrome and the perinatal period: Lower birth weight increases the risk. Neurogastroenterol Motil. 28:1518–1524. 2016. View Article : Google Scholar
15	Leybovitz-Haleluya N, Wainstock T, Sheiner E, Segal I, Landau D and Walfisch A: Low Apgar scores in term newborns and long-term gastro-intestinal morbidity: A population-based cohort study with up to 18 years of follow-up. J Matern Fetal Neonatal Med. 32:1609–1614. 2019. View Article : Google Scholar : PubMed/NCBI
16	Vayssière C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, Gascoin G, Gaudineau A, Grangé G, Houfflin-Debarge V, et al: Fetal growth restriction and intra-uterine growth restriction: Guidelines for clinical practice from the French college of gynaecologists and obstretricians. Eur J Obstet Gynecol Reprod Biol. 193:10–18. 2015. View Article : Google Scholar
17	Berglund G, Elmstähl S, Janzon L and Larsson SA: The Malmo diet and cancer study. Design and feasibility. J Intern Med. 233:45–51. 1993. View Article : Google Scholar : PubMed/NCBI
18	Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engström G, Wang TJ and Melander O: Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 56:1712–1719. 2010. View Article : Google Scholar
19	Brunkwall L, Jönsson D, Ericson U, Hellstrand S, Kennbäck C, Östling G, Jujic A, Melander O, Engström G, Nilsson J, et al: The Malmö offspring study (MOS): Design, methods and first results. Eur J Epidemiol. 36:103–116. 2021. View Article : Google Scholar
20	Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F and Spiller RC: Functional bowel disorders. Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
21	Bengtsson M, Ohlsson B and Ulander K: Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 7:162007. View Article : Google Scholar
22	Ohlsson B, Orho-Melander M and Nilsson PM: Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestation. Int J Mol Sci. 18:5822017. View Article : Google Scholar
23	Wennerberg J, Sharma S, Nilsson PM and Ohlsson B: A possible association between early life factors and burden of functional bowel symptoms in adulthood. Scand J Prim Health Care. 39:506–514. 2021. View Article : Google Scholar : PubMed/NCBI
24	Brunkwall L, Ericson U, Nilsson PM, Orho-Melander M and Ohlsson B: Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort. J Gastroenterol Hepatol. 36:174–180. 2021. View Article : Google Scholar
25	Nilsson D and Ohlsson B: Gastrointestinal symptoms and irritable bowel syndrome are associated with female sex and smoking in the general population and with unemployment in men. Front Med (Lausanne). 8:6466582021. View Article : Google Scholar : PubMed/NCBI
26	Zejnelagic J and Ohlsson B: Chronic stress and poor sleeping habits are associated with self-reported IBS and poor psychological well-being in the general population. BMC Res Notes. 14:2802021. View Article : Google Scholar : PubMed/NCBI
27	Ruderstam H and Ohlsson B: Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases. Scand J Gastroenterol. Feb 1–2022.(Epub ahead of print). doi: 10.1080/00365521.2022.2031281. View Article : Google Scholar
28	Palma J, Antoniewicz J, Borecki K, Tejchman K, Skonieczna-Żydecka K, Maciejewska-Markiewicz D, Ryterska K, Komorniak N, Czerwińska-Rogowska M, Wolska A, et al: Irritable bowel syndrome prevalence among participants of woodstock rock festival in Poland based on Rome IV criteria questionnaire. Int J Environ Res Public Health. 18:114642021. View Article : Google Scholar : PubMed/NCBI
29	Chen J, Barandouzi ZA, Lee J, Xu W, Feng B, Starkweather A and Cong X: Psychosocial and sensory factors contribute to self-reported pain and quality of life in young adults with irritable bowel syndrome. Pain Manag Nurs. Jan 21–2022.(Epub ahead of print). doi: 10.1016/j.pmn.2021.12.004. View Article : Google Scholar
30	Zhang C, Zhang J, Wang Y, Lang R, Su L, Yu M, Zhao X, Yang G and Ren Z: Association between breakfast consumption frequency and the risk of irritable bowel syndrome among Chinese female college students: A cross-sectional study. Medicine (Baltimore). 100:e275412021. View Article : Google Scholar : PubMed/NCBI
31	Hellström PM: Pathophysiology of the irritable bowel syndrome-reflections of today. Best Pract Res Clin Gastroenterol. 40–41. 1016202019.
32	Lindberg G: Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Best Pract Res Clin Gastroenterol. 40–41. 1016352019.
33	Artazcoz L, Benach J, Borrell C and Cortès I: Unemployment and mental health: Understanding the interactions among gender, family roles, and social class. Am J Public Health. 94:82–88. 2004. View Article : Google Scholar : PubMed/NCBI
34	Neubert M, Süssenbach P, Rief W and Euteneuer F: Unemployment and mental health in the German population: The role of subjective social status. Psychol Res Behav Manag. 12:557–564. 2019. View Article : Google Scholar : PubMed/NCBI
35	Tang NKY, Goodchild CE, Sanborn AN, Howard J and Salkovskis PM: Deciphering the temporal link between pain and sleep in a heterogeneous chronic pain patient sample: A multilevel daily process study. Sleep. 35:675–687A. 2012.PubMed/NCBI
36	Buchanan DT, Cain K, Heitkemper M, Burr R, Vitiello MV, Zia J and Jarrett M: Sleep measures predict next-day symptoms in women with irritable bowel syndrome. J Clin Sleep Med. 10:1003–1009. 2014. View Article : Google Scholar : PubMed/NCBI
37	Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP and Sayuk GS: Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 44:246–258. 2016. View Article : Google Scholar : PubMed/NCBI
38	Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A and Tarasiuk A: Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep. 26:747–752. 2003. View Article : Google Scholar : PubMed/NCBI
39	Fosnes GS, Lydersen S and Farup PG: Constipation and diarrhoea-common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol. 11:22011. View Article : Google Scholar
40	Whitehead WE, Winget C, Fedoravicius AS, Wooley S and Blackwell B: Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci. 27:202–208. 1982. View Article : Google Scholar
41	Levy RL, Whitehead WE, Von Korff MR and Feld AD: Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol. 95:451–456. 2000. View Article : Google Scholar
42	Bengtson MB, T Rønning T, Vatn MH and Harris JR: Irritable bowel syndrome in twins: Genes and environment. Gut. 55:1754–1759. 2006. View Article : Google Scholar
43	Waehrens R, Ohlsson H, Sundquist J, Sundquist K and Zöller B: Risk of irritable bowel syndrome in first-degree, second-degree and third-degree relatives of affected individuals: A nationwide family study in Sweden. Gut. 64:215–221. 2015. View Article : Google Scholar
44	Wang X, Memon AA, Palmér K, Hedelius A, Sundquist J and Sundquist K: The association of zonulin-related proteins with prevalent and incident inflammatory bowel disease. BMC Gastroenterol. 22:32022. View Article : Google Scholar
45	Hugerth LW, Andreasson A, Talley NJ, Forsberg AM, Kjellström L, Schmidt PT, Agreus L and Engstrand L: No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut. 69:1076–1084. 2020. View Article : Google Scholar
46	Algera J, Colomier E and Simrén M: The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients. 11:21622019. View Article : Google Scholar